Collagen type 1 retards tube formation by human microvascular endothelial cells in a fibrin matrix

Angiogenesis

Volumn 5, Issue 4, 2002, Pages 257-265

  Kroon, Marielle E ^a   Van Schiel, Marianke L J ^a   Van Der Vecht, Bea ^a   Van Hinsbergh, Victor W M ^a,b   Koolwijk, Pieter ^a  

^a TNO   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Angiogenesis; Collagen type 1; Endothelial cell; Fibrin; Matrix; Matrix metalloproteinases, neovascularisation; Urokinase

Indexed keywords

COLLAGEN TYPE 1; FIBRIN; FIBROBLAST GROWTH FACTOR 2; MATRIX METALLOPROTEINASE; PLASMIN; PROCOLLAGEN; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ARTICLE; CAPILLARY; CONCENTRATION RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANOXIA; CELL CULTURE TECHNIQUES; COLLAGEN TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FIBRIN; HUMANS; MATRIX METALLOPROTEINASES; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC; URINARY PLASMINOGEN ACTIVATOR;

EID: 0037766282     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024540701634     Document Type: Article

References (47)

1. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-57.
2. Chang C, Werb Z. The many faces of metalloproteases: Cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 2001; 11: S37-43.
3. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001; 21: 1104-17.
4. McClain SA, Simon M, Jones E et al. Mesenchymal cell activation is the rate-limiting step of granulation tissue induction. Am J Pathol 1996; 149: 1257-70.
5. Welch MP, Odland GF, Clark RA. Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Cell Biol 1990; 110: 133-45.
6. Clark RA, Lanigan JM, DellaPelle P et al. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 1982; 79: 264-69.
7. Langholz O, Rockel D, Mauch C et al. Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol 1995; 131: 1903-15.
8. Gaffney PJ. Fibrin(-ogen) interactions with plasmin. Haemostasis 1977; 6: 2-25.
9. Blasi F. Urokinase and urokinase receptor - a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 1993; 15: 105-11.
10. Koolwijk P, Van Erck MGM, De Vree WJA et al. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix, role of urokinase activity. J Cell Biol 1996; 132: 1177-88.
11. Kroon ME, Koolwijk P, Van Goor H et al. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices. Am J Pathol 1999; 154: 1731-42.
12. Werb Z. ECM and cell surface proteolysis: Regulating cellular ecology. Cell 1997; 91: 439-42.
13. Nagase H, Woessner JFJ. Matrix metalloproteinases. J Biol Chem 1999; 274: 21,491-4.
14. Galardy RE, Grobelny D, Foellmer HG, Fernandez LA. Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)-4-methylpentanoyl)]-L-tryptophan methylamide. Cancer Res 1994; 54: 4715-8.
15. Wojtowicz-Praga S, Low J, Marshall J et al. Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer. Invest New Drugs 1996; 14: 193-202.
16. Van Hinsbergh VWM, Van den Berg EA, Fiers W, Dooijewaard G. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells. Blood 1990; 75: 1991-98.
17. Mignatti P, Mazzieri R, Rifkin DB. Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J Cell Biol 1991; 113: 1193-201.
18. Hotary K, Allen E, Punturieri A et al. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 2000; 149: 1309-23.
19. Zucker S, Mirza H, Conner CE et al. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 1998; 75: 780-6.
20. Pepper MS, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991; 181: 902-6.
21. Graham CH, Fitzpatrick TE, McCrae KR. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood 1998; 91: 3300-7.
22. Kroon ME, Koolwijk P, Van der Vecht B, Van Hinsbergh VWM. Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: Implications for capillary-like tube formation in a fibrin matrix. Blood 2000; 96: 2775-83.
23. Himelstein BP, Koch CJ. Studies of type IV collagenase regulation by hypoxia. Cancer Lett 1998; 124: 127-33.
24. Koong AC, Denko NC, Hudson KM et al. Candidate genes for the hypoxic tumor phenotype. Cancer Res 2000; 6: 883-7.
25. Steinbrech DS, Longaker MT, Mehrara BJ et al. Fibroblast response to hypoxia: The relationship between angiogenesis and matrix regulation. J Surg Res 1999; 84: 127-33.
26. Orphanides C, Fine LG, Norman JT. Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism. Kidney Int 1997; 52: 637-47.
27. Wijngaards G, Kluft C, Groeneveld E. Demonstration of urokinase-related fibrinolytic activity in human plasma. Br J Haematol 1982; 51: 165-9.
28. Bohuslav J, Horejsi V, Hansmann C et al. Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med 1995; 181: 1381-90.
29. Angel P, Baumann I, Stein B et al. 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol Cell Biol 1987; 7: 2256-66.
30. Matrisian LM, Glaichenhaus N, Gesnel MC, Breathnach R. Epider mal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts. EMBO J 1985; 4: 1435-40.
31. Dodemont H J, Soriano P, Quax WJ et al. The genes coding for the cytoskeletal proteins actin and vimentin in warm-blooded vertebrates. EMBO J 1982; 1: 167-71.
32. Van Hinsbergh VWM, Sprengers ED, Kooistra T. Effect of thrombin on the production of plasminogen activators and PA inhibitor-I by human foreskin microvascular endothelial cells. Thromb Haemost 1987; 57: 148-53.
33. Defilippi P, Van Hinsbergh VWM, Bertolotto A et al. Differential distribution and modulation of expression of alpha 1/beta 1 integrin on human endothelial cells. J Cell Biol 199 1; 114: 855-63.
34. Strom SC, Michalopoulos G. Collagen as a substrate for cell growth and differentiation. Methods Enzymol 1982; 82 Pt A: 544-55.
35. Koolwijk P, Sidenius N, Peters E et al. Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: Implication for angiogenesis in fibrin matrices. Blood 2001; 97: 3123-31.
36. Hiraoka N, Allen E, Apel IQ et al. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 1998; 95: 365-77.
37. Dvorak HF, Harvey S, Estrella P et al. Fibrin containing gels induce angiogenesis: Implications for tumor stroma generation and wound healing. Lab Invest. 1987; 57: 673-86.
38. Nicosia RF, Ottinetti A. Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: A comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot. In Vitro Cell Dev Biol 1990; 26: 119-28.
39. Nair CH, Shah GA, Dhall DP. Effect of temperature, pH and ionic strength and composition on fibrin network structure and its development. Thromb Res 1986; 42: 809-16.
40. Elgue G, Sanchez J, Fatah K et al. The effect of plasma antithrombin concentration on thrombin generation and fibrin gel structure. Thromb Res 1994; 75: 203-12.
41. Collen A, Koolwijk P, Kroon ME, Van Hinsbergh VWM. Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells. Angiogenesis 1998; 2: 153-65.
42. Vernon RB, Sage EH. A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices. Microvasc Res 1999; 57: 118-33.
43. Haas TL, Davis SJ, Madri JA. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J Biol Chem 1998; 273: 3604-10.
44. Hanemaaijer R, Koolwijk P, Leclercq L et al. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells - effects of tumour necrosis factor-alpha, interleukin-1 and phorbol ester. Biochem J 1993; 296: 803-9.
45. O'Reilly MS, Boehm T, Shing Y et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-85.
46. Maeshima Y, Colorado PC, Torre A et al. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem 2000; 275: 21,340-8.
47. Colorado PC, Torre A, Kamphaus G et al. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res 2000; 60: 2520-6.